1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs of Abuse Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Psychostimulants
1.2.3 Narcotic
1.2.4 Hallucinogens
1.2.5 Sedatives
1.2.6 Others
1.3 Market by Application
1.3.1 Global Drugs of Abuse Testing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Diagnostics Laboratories
1.3.4 Forensic Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drugs of Abuse Testing Market Perspective (2017-2028)
2.2 Drugs of Abuse Testing Growth Trends by Region
2.2.1 Drugs of Abuse Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Drugs of Abuse Testing Historic Market Size by Region (2017-2022)
2.2.3 Drugs of Abuse Testing Forecasted Market Size by Region (2023-2028)
2.3 Drugs of Abuse Testing Market Dynamics
2.3.1 Drugs of Abuse Testing Industry Trends
2.3.2 Drugs of Abuse Testing Market Drivers
2.3.3 Drugs of Abuse Testing Market Challenges
2.3.4 Drugs of Abuse Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs of Abuse Testing Players by Revenue
3.1.1 Global Top Drugs of Abuse Testing Players by Revenue (2017-2022)
3.1.2 Global Drugs of Abuse Testing Revenue Market Share by Players (2017-2022)
3.2 Global Drugs of Abuse Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drugs of Abuse Testing Revenue
3.4 Global Drugs of Abuse Testing Market Concentration Ratio
3.4.1 Global Drugs of Abuse Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs of Abuse Testing Revenue in 2021
3.5 Drugs of Abuse Testing Key Players Head office and Area Served
3.6 Key Players Drugs of Abuse Testing Product Solution and Service
3.7 Date of Enter into Drugs of Abuse Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs of Abuse Testing Breakdown Data by Type
4.1 Global Drugs of Abuse Testing Historic Market Size by Type (2017-2022)
4.2 Global Drugs of Abuse Testing Forecasted Market Size by Type (2023-2028)
5 Drugs of Abuse Testing Breakdown Data by Application
5.1 Global Drugs of Abuse Testing Historic Market Size by Application (2017-2022)
5.2 Global Drugs of Abuse Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Drugs of Abuse Testing Market Size (2017-2028)
6.2 North America Drugs of Abuse Testing Market Size by Country (2017-2022)
6.3 North America Drugs of Abuse Testing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Drugs of Abuse Testing Market Size (2017-2028)
7.2 Europe Drugs of Abuse Testing Market Size by Country (2017-2022)
7.3 Europe Drugs of Abuse Testing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs of Abuse Testing Market Size (2017-2028)
8.2 Asia-Pacific Drugs of Abuse Testing Market Size by Country (2017-2022)
8.3 Asia-Pacific Drugs of Abuse Testing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Drugs of Abuse Testing Market Size (2017-2028)
9.2 Latin America Drugs of Abuse Testing Market Size by Country (2017-2022)
9.3 Latin America Drugs of Abuse Testing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs of Abuse Testing Market Size (2017-2028)
10.2 Middle East & Africa Drugs of Abuse Testing Market Size by Country (2017-2022)
10.3 Middle East & Africa Drugs of Abuse Testing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Quest Diagnostics
11.1.1 Quest Diagnostics Company Detail
11.1.2 Quest Diagnostics Business Overview
11.1.3 Quest Diagnostics Drugs of Abuse Testing Introduction
11.1.4 Quest Diagnostics Revenue in Drugs of Abuse Testing Business (2017-2022)
11.1.5 Quest Diagnostics Recent Development
11.2 F. Hoffmann La-Roche
11.2.1 F. Hoffmann La-Roche Company Detail
11.2.2 F. Hoffmann La-Roche Business Overview
11.2.3 F. Hoffmann La-Roche Drugs of Abuse Testing Introduction
11.2.4 F. Hoffmann La-Roche Revenue in Drugs of Abuse Testing Business (2017-2022)
11.2.5 F. Hoffmann La-Roche Recent Development
11.3 Siemens
11.3.1 Siemens Company Detail
11.3.2 Siemens Business Overview
11.3.3 Siemens Drugs of Abuse Testing Introduction
11.3.4 Siemens Revenue in Drugs of Abuse Testing Business (2017-2022)
11.3.5 Siemens Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Drugs of Abuse Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Drugs of Abuse Testing Business (2017-2022)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Drugs of Abuse Testing Introduction
11.5.4 Abbott Revenue in Drugs of Abuse Testing Business (2017-2022)
11.5.5 Abbott Recent Development
11.6 Shimadzu
11.6.1 Shimadzu Company Detail
11.6.2 Shimadzu Business Overview
11.6.3 Shimadzu Drugs of Abuse Testing Introduction
11.6.4 Shimadzu Revenue in Drugs of Abuse Testing Business (2017-2022)
11.6.5 Shimadzu Recent Development
11.7 Laboratory Corporation of America
11.7.1 Laboratory Corporation of America Company Detail
11.7.2 Laboratory Corporation of America Business Overview
11.7.3 Laboratory Corporation of America Drugs of Abuse Testing Introduction
11.7.4 Laboratory Corporation of America Revenue in Drugs of Abuse Testing Business (2017-2022)
11.7.5 Laboratory Corporation of America Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
